As per MRFR analysis, the South Korea Structural Heart Devices Market Size was estimated at 17.75 (USD Million) in 2024.The South Korea Structural Heart Devices Market Industry is expected to grow from 19.25(USD Million) in 2025 to 45.6 (USD Million) by 2035. The South Korea Structural Heart Devices Market CAGR (growth rate) is expected to be around 8.155% during the forecast period (2025 - 2035).
The South Korea Structural Heart Devices Market is currently experiencing significant trends driven by an increase in cardiovascular diseases and a growing aging population. The government of South Korea has prioritized healthcare improvements, leading to heightened awareness about heart diseases, which is prompting more patients to seek treatment.
This rise in patient numbers is a key market driver, motivating healthcare providers to invest in advanced technologies and innovations in structural heart devices. With a strong emphasis on improving healthcare infrastructure, South Korea is enhancing its hospital systems which, in turn, supports the availability and adoption of these medical devices.In recent times, there has been a notable shift toward minimally invasive procedures. Many South Korean hospitals are adopting techniques that reduce recovery time and associated risks, which is appealing to patients and healthcare professionals alike.
This trend toward less invasive surgical approaches is also fostered by education and training initiatives aimed at upskilling medical personnel in novel techniques and technologies. Additionally, collaborations between local companies and international firms are creating opportunities for product development and market expansion within this segment. There is also an opportunity for the market to explore advancements in digital healthcare and telemedicine, especially in the context of post-operative care and remote patient monitoring.
The integration of artificial intelligence and machine learning in device functionality presents a chance to enhance patient outcomes and streamline processes. As healthcare policies evolve and investment in health technology increases, there is a promising landscape for the growth and diversification of structural heart devices in South Korea, making it essential for stakeholders to stay attuned to these trends.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The aging population in South Korea is a significant driver for the South Korea Structural Heart Devices Market Industry. According to the Korean Statistical Information Service, the proportion of individuals aged 65 and older is projected to reach 24.3% by 2030, up from 18.9% in 2020. This rising demographic segment typically exhibits a higher incidence of cardiovascular diseases, which necessitate advanced treatment options such as structural heart devices.
Major healthcare organizations, including the Korea National Health Insurance Service, are reporting increased healthcare spending focused on cardiovascular health. As a result, there has been a consistent demand for innovative solutions to manage heart diseases, paving the way for the growth of the structural heart devices market. This trend is expected to persist as healthcare systems adapt to cater to the specific needs of an aging population, fostering innovation and investment in the structural heart device sector.
Recent advancements in minimally invasive surgical techniques are propelling the growth of the South Korea Structural Heart Devices Market Industry. The introduction of cutting-edge procedures, such as transcatheter aortic valve replacement (TAVR) and left atrial appendage closure, has expanded the treatment landscape for patients with structural heart conditions.
According to the Ministry of Health and Welfare in South Korea, the adoption of these advanced techniques has led to a 15% increase in successful surgical outcomes among older patients.Established companies such as Abbott Laboratories and Boston Scientific are at the forefront of this innovation, developing devices that enhance patient safety and recovery. As these technological advancements continue to emerge, they significantly contribute to market growth by increasing the acceptance of these procedures among healthcare professionals and patients alike.
The South Korean government has the importance of cardiovascular health and is implementing initiatives aimed at enhancing cardiac care, which directly benefits the South Korea Structural Heart Devices Market Industry. The Health Insurance Review and Assessment Service has launched programs that allocate increased funding for advanced cardiac procedures and devices. In 2022, the government invested approximately 20 million USD into research grants aimed at developing new structural heart interventions.
These initiatives help incorporate new devices and technologies into the healthcare system, which makes it easier for patients to access health services. This support from the government not only enhances local production but also stimulates international partnerships, attracting more important healthcare industry attention and investment into the market.
Growing awareness about cardiovascular health and an increase in screening initiatives are significantly bolstering the South Korea Structural Heart Devices Market Industry. The Korean Cardiac Society reports that public health campaigns have led to a 30% increase in regular cardiac screening among adults aged 40 and over. This heightened awareness has resulted in earlier diagnoses of structural heart conditions, creating a growing need for treatment solutions.Prominent healthcare organizations like the Korean Society of Cardiology are actively promoting education regarding heart health, further facilitating early intervention. This trend is catalyzing demand for structural heart devices as patients become more informed about their health and healthcare providers are equipped to provide necessary treatment options in a timely manner.
The South Korea Structural Heart Devices Market has shown a notable growth trajectory, with Type-based segmentation revealing key insights into its components, including Heart Valve Devices, Annuloplasty Rings, Occluders, and Delivery Systems. Heart Valve Devices represent a critical sector within this market, vital for treating various valvular heart diseases.
the aging population in South Korea and the rising prevalence of heart-related conditions, there is an increasing demand for innovative and effective heart valve replacement technologies.Similarly, Annuloplasty Rings play an essential role in the treatment of heart valve malfunctions, offering stability and durability during surgical procedures, thus contributing to improved patient outcomes. Occluders, which are pivotal in treating structural heart defects such as atrial septal defects, are also gaining traction.
Their significance stems from their minimally invasive nature, leading to shorter recovery times and reducing the overall healthcare burden. Delivery Systems are crucial as they facilitate the implantation of structural heart devices effectively and safely.The advancements in technology related to these systems enhance procedural efficiency and patient safety. Overall, the segmentation in the South Korea Structural Heart Devices Market underscores the sophisticated landscape of heart care, shaped by emerging technologies and a growing need for effective interventions in the face of rising cardiovascular diseases in the region. As a result, each component plays a significant and interrelated role in enhancing the standard of heart care in South Korea, affirming the importance of continued innovation to meet the evolving health needs of its population.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The South Korea Structural Heart Devices Market showcases a distinct segmentation based on Indication, prominently featuring Valvular Heart Disease and Cardiomyopathy. Valvular Heart Disease is significant within the South Korean healthcare landscape due to the rising prevalence of age-related conditions, leading to increased healthcare demand for innovative solutions. Similarly, Cardiomyopathy, affecting the heart muscle's ability to pump blood, requires specialized structural devices to enhance patient care.
The growing aging population in South Korea, coupled with advancements in technology and surgical techniques, is further propelling the demand for these particular indications in structural heart interventions.As healthcare providers strive towards improved outcomes and quality of life for patients, these segments are poised to play a critical role in shaping the future of cardiac care in the region. With the emphasis on expanding treatment options and expanding accessibility, stakeholders are increasingly investing in Research and Development initiatives for these indications, ensuring a robust growth trajectory for the market.
The South Korea Structural Heart Devices Market, focusing on the Procedure segment, showcases significant growth driven by advancements in medical technology and an aging population. Replacement Procedures, which involve the substitution of damaged heart structures, often dominate this segment due to their critical nature in treating severe cardiovascular conditions. This aspect is further bolstered by increasing cardiovascular disease prevalence in South Korea, prompting a need for innovative solutions.
On the other hand, Repair Procedures aimed at fixing existing heart structures play a crucial role in addressing less severe but still problematic heart anomalies.Their significance lies in the ability to minimize patient recovery time and associated costs. As healthcare infrastructure in South Korea continues to evolve and more clinicians adopt advanced techniques, a considerable portion of the South Korea Structural Heart Devices Market will likely be driven by both Replacement and Repair Procedures, focusing on improving patient outcomes and reducing the burden of heart diseases. The combination of demographic trends and technological improvements poised to enhance the overall efficacy of procedures in this market, reflecting wider market trends and aligning with global best practices in cardiac care.
The South Korea Structural Heart Devices Market is a rapidly evolving sector within the medical devices industry, characterized by significant advancements and competitive dynamics. As the prevalence of cardiovascular diseases continues to rise, the demand for structural heart interventions has surged, leading to increased innovation and investment in this market. The competitive landscape is shaped by a mix of established players and emerging companies that are focusing on developing novel therapies and devices to address a range of structural heart conditions.
The market is marked by continuous advancements in technology, regulatory changes, and evolving patient needs, compelling companies to constantly adapt their strategies to maintain a competitive edge.Transcatheter Technologies has solidified its presence in the South Korea Structural Heart Devices Market through its commitment to providing innovative transcatheter solutions for cardiac conditions. The company's strengths lie in its advanced technology, which aims to enhance procedural efficiencies and improve patient outcomes.
Their emphasis on research and development has led to a robust portfolio that addresses various structural heart issues through minimally invasive approaches. With a strong focus on clinical efficacy and patient safety, Transcatheter Technologies has developed a reputation for delivering high-quality devices. The company’s strategic collaborations with healthcare institutions and continued engagement in clinical trials further augment its competitive position within the South Korean market, underscoring its commitment to pioneering advancements in heart health.Medtronic stands as a formidable player in the South Korea Structural Heart Devices Market, leveraging its extensive experience and market reach. Known for its comprehensive range of products, Medtronic offers various structural heart devices designed to treat conditions such as valvular heart diseases and congenital heart defects.
The company benefits from strong brand recognition, which has been built through continuous innovation and strategic mergers and acquisitions aimed at enhancing its product offerings. Medtronic's key product line includes transcatheter heart valves and devices that facilitate minimally invasive procedures, thus significantly improving surgical outcomes. Its proactive approach to engaging with healthcare professionals and participating in regional medical conferences strengthens its market presence and fosters strategic partnerships. This enables Medtronic to stay at the forefront of the industry, continuously addressing the evolving needs of the South Korean population while maintaining a focus on enhancing patient care through technologically advanced solutions.
In recent months, the South Korea Structural Heart Devices Market has seen significant advancements, with major players like Medtronic, Abbott Laboratories, and Edwards Lifesciences actively expanding their portfolios to meet growing demand. Medtronic launched its latest transcatheter aortic valve replacement technology in March 2023, aimed at improving surgical outcomes. Meanwhile, Abbott Laboratories introduced new features in their heart monitoring systems, enhancing patient care. In terms of mergers and acquisitions, Corindus Vascular Robotics completed an acquisition by Siemens Healthineers in September 2022, strengthening their market position.
The growing prevalence of heart diseases in South Korea has spurred investment in innovative solutions, leading to an estimated market valuation growth of 8.5% in the past year alone, contributing to enhanced treatment options for patients. Various companies, including Boston Scientific and CryoLife, have also invested in local Research and Development initiatives to adapt to South Korean healthcare regulations. The consistent emphasis on quality and regulatory compliance by the South Korean government is paving the way for advanced structural heart devices, thereby influencing market dynamics and encouraging technological collaborations among leading organizations in the sector.
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 17.75(USD Million) |
| MARKET SIZE 2024 | 19.25(USD Million) |
| MARKET SIZE 2035 | 45.6(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.155% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Transcatheter Technologies, Medtronic, Corindus Vascular Robotics, Abbott Laboratories, Cardiac Dimensions, Nuvem, Boston Scientific, Cameron Health, Fumedica, Aortica Corporation, SentreHEART, Edwards Lifesciences, CryoLife, Vascular Dynamics, LivaNova |
| SEGMENTS COVERED | Type, Indication, Procedure |
| KEY MARKET OPPORTUNITIES | Aging population demand, Emerging minimally invasive procedures, Advanced biomaterials innovation, Increased healthcare expenditure, Growing awareness of heart diseases |
| KEY MARKET DYNAMICS | aging population, increasing prevalence of cardiovascular diseases, advancement in minimally invasive procedures, growing awareness of treatment options, rise in healthcare investments |
| COUNTRIES COVERED | South Korea |
Frequently Asked Questions (FAQ) :
The South Korea Structural Heart Devices Market is expected to be valued at 19.25 million USD in 2024.
By 2035, the South Korea Structural Heart Devices Market is anticipated to reach a value of 45.6 million USD.
The expected CAGR for the South Korea Structural Heart Devices Market from 2025 to 2035 is 8.155 percent.
Heart Valve Devices are projected to have the highest market value of 19.6 million USD in 2035.
The market size for Annuloplasty Rings is estimated to be 4.5 million USD in 2024.
Major players in the market include Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences, and several others.
The expected market value for Occluders is forecasted to be 8.2 million USD by 2035.
The projected market size for Delivery Systems in 2024 is 3.0 million USD.
Potential growth drivers for the market include advancements in technology and increasing prevalence of structural heart diseases.
The competitive landscape is shaped by leading companies such as Transcatheter Technologies, Corindus Vascular Robotics, and LivaNova among others.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
